Literature DB >> 7836921

Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

A Sette1, S Southwood, J Miller, E Appella.   

Abstract

Major histocompatibility complex class II-associated invariant chain (Ii) provides several important functions that regulate class II expression and function. One of these is the ability to inhibit class II peptide loading early in biosynthesis. This allows for efficient class II folding and egress from the endoplasmic reticulum, and protects the class II peptide binding site from loading with peptides before entry into endosomal compartments. The ability of Ii to interact with class II and interfere with peptide loading has been mapped to Ii exon 3, which encodes amino acids 82-107. This same region of Ii has been described as a nested set of class II-associated Ii peptides (CLIPs) that are transiently associated with class II in normal cells and accumulate in human histocompatibility leukocyte antigen-DM-negative cell lines. Currently it is not clear how CLIP and the CLIP region of Ii blocks peptide binding. CLIP may bind directly to the class II peptide binding site, or may bind elsewhere on class II and modulate class II peptide binding allosterically. In this report, we show that CLIP can interact with many different murine and human class II molecules, but that the affinity of this interaction is controlled by polymorphic residues in the class II chains. Likewise, structural changes in CLIP also modulate class II binding in an allele-dependent manner. Finally, the specificity and kinetics of CLIP binding to class II molecule is similar to antigenic peptide binding to class II. These data indicate that CLIP binds to class II in an analogous fashion as conventional antigenic peptides, suggesting that the CLIP segment of Ii may actually occupy the class II peptide binding site.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836921      PMCID: PMC2191868          DOI: 10.1084/jem.181.2.677

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

Review 1.  MHC class II antigen processing: biology of invariant chain.

Authors:  A J Sant; J Miller
Journal:  Curr Opin Immunol       Date:  1994-02       Impact factor: 7.486

2.  HLA-DMA and -DMB genes are both required for MHC class II/peptide complex formation in antigen-presenting cells.

Authors:  S P Fling; B Arp; D Pious
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

3.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.

Authors:  P Morris; J Shaman; M Attaya; M Amaya; S Goodman; C Bergman; J J Monaco; E Mellins
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

4.  Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.

Authors:  E O Long; T LaVaute; V Pinet; D Jaraquemada
Journal:  J Immunol       Date:  1994-08-15       Impact factor: 5.422

5.  Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.

Authors:  M J Bijlmakers; P Benaroch; H L Ploegh
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

6.  Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment.

Authors:  C G Odorizzi; I S Trowbridge; L Xue; C R Hopkins; C D Davis; J F Collawn
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

7.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.

Authors:  R G Urban; R M Chicz; J L Strominger
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

8.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

9.  Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.

Authors:  J M Riberdy; R R Avva; H J Geuze; P Cresswell
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

10.  Mapping functional regions in the lumenal domain of the class II-associated invariant chain.

Authors:  M J Bijlmakers; P Benaroch; H L Ploegh
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

View more
  45 in total

Review 1.  HLA-DM and the MHC class II antigen presentation pathway.

Authors:  P E Jensen; D A Weber; W P Thayer; X Chen; C T Dao
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Dissociation of peripheral T cell responses from thymocyte negative selection by weak agonists supports a spare receptor model of T cell activation.

Authors:  Lisa K McNeil; Brian D Evavold
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

4.  An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice.

Authors:  Paula R Menges; Scott A Jenks; Elizabeth K Bikoff; David R Friedmann; Zackery A G Knowlden; Andrea J Sant
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  CD74 Deficiency Mitigates Systemic Lupus Erythematosus-like Autoimmunity and Pathological Findings in Mice.

Authors:  Yi Zhou; Huimei Chen; Li Liu; Xueqing Yu; Galina K Sukhova; Min Yang; Lijun Zhang; Vasileios C Kyttaris; George C Tsokos; Isaac E Stillman; Takaharu Ichimura; Joseph V Bonventre; Peter Libby; Guo-Ping Shi
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

Review 6.  Protein sorting within the MHC class II antigen-processing pathway.

Authors:  M S Marks
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 7.  Selection of the MHC class II-associated peptide repertoire by HLA-DM.

Authors:  S O Arndt; A B Vogt; G J Hämmerling; H Kropshofer
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

8.  A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

Authors:  H Kropshofer; A B Vogt; C Thery; E A Armandola; B C Li; G Moldenhauer; S Amigorena; G J Hämmerling
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

9.  Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.

Authors:  P Stumptner; P Benaroch
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

10.  In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM.

Authors:  L Lightstone; R Hargreaves; G Bobek; M Peterson; G Aichinger; G Lombardi; R Lechler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.